focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Point is you could have bought Redx at 4.4p and sold 29p with a crystal ball. They are spectacular gains.
Anyway that 5 million at 0.137p just now is mine, not often I buy something where I'm down thousands instantly on the spread but I think the mm's are going to struggle to get enough sellers at 0.12p levels to match the buyers so I see it recovering in the 0.2-0.3p range
Davey50
Red x and men - yeah they looking good now but when they were on aim shareholders did not get anything. so even if red x trading now 16p the old shareholders have cancelled shares on their isa and waiting for return. if the company will return return with different name etc.
I wondered that too dozer, while watching the interview. Whoever invests will still be providing the same a amount of money whether it's listed or private. Perhaps when private the company can dictate their own terms, but when listed they are beholden to the market - who knows.
Ms Sowmimo added: “We anticipate that as an unlisted company, a far larger pool of capital may be available to us, and therefore it is right for us to make this change.” Why would this be the case? Surely the risk is the same whether the company is listed or unlisted? Maybe not - at least an unlisted company can't delist and crash the SP!
I've not bought Octp yet but watching, some of these delisting stocks for some reason have the most spectacular gains from lows.
Redx dropped to 4-4.5p low then spiked to 30-33p
Men dropped to 3-4p then spiked to 22-25p
For now the mm's are messing around fleecing those that want to move on with their cash but at some point it would not surprise me if they spike this one too
TK44
I am not sure what your life experiences are, but your observations, draws your own conclusions, about someones personality and what their intentions are. I dont have to agree with them. You made assumptions whether right or wrong on someone you may have never met but from the outset, you never listened to what was said rather you observed what YOU wanted to confirm for your outcome. You could be way off the mark, you could be right, so you decide what is the best route for you.
You might be right that she could not care less about her shares, but you would be completely wrong in that she and the other BODs are not responsible to other shareholders. There are a lot of reputations on the line. You have nothing against say Jeremy Hunt who slashed CGT this year to £3000? which in turn stops a lot of people wanting to invest? which may have impacted stocks like OCTP, or nothing against the FCA for their continuous destruction of the markets with zealous rules? which again is the reason this company and many others are in this predicament, of not being able to raise finance unless making compromises which in other circumstances would make no difference? or the continuous pumping of economic finances into wars that leave people at home in a destitute situations with cuts being made everywhere to fund those wars. No Clarissas earrings being worth more than her holdings, is what made you decide, this is not worth holding.
Though no one likes money being tied up where you cannot get hold of it, at your own choice, its wiser to assess what would be the best option personally, and everyone has till the 6th June to decide.
Countingcards
she have maybe 2.5m shares worth less that her earrings in the video. of course she will keep them as they are worthless now she prepared to loose that. (as 10000% sure existing shareholders will loose all of money, will get nothing. post cancellation trades will be on 0.000001 level). she can rake out from the company way more as a cég than those few shares. :) I understand need to be positive and hope. but this is gone forever.
Following this debacle and others in recent weeks, I have gone through my portfolio with a fine tooth comb and sold every one of my AIM holdings, replacing them with FTSE 250 companies. A shame really but it is what it is.
How many shares she have? 1.5million???
British biotech start-up backed by Snoop Dogg has unveiled plans to ditch the “turbulent” London stock market, dealing a fresh blow to the beleaguered exchange.
Oxford Cannabinoid Technologies said it was delisting from London following a “continuous, irrational and regressive pressure” on its share price. The company claimed it would be much better valued as a private company and would also not have to bear the “substantial cost” of maintaining a public listing.
Clarissa Sowemimo-Coker, chief executive of Oxford Cannabinoid Technologies, said: “It has been a turbulent time on the capital markets pretty much since we listed. The last 12 to 24 months have been especially challenging for small caps and particularly in the biopharma space. Companies have lost 80pc or 90pc of their value and once you’re down there, it’s very difficult to make any inroads to start climbing back up again.”
She said this was having knock-on effects when it came to bringing new treatments to market: “Things do take longer when you’re trying to stretch for capital. You inevitably slow down drug development.”
Ms Sowmimo added: “We anticipate that as an unlisted company, a far larger pool of capital may be available to us, and therefore it is right for us to make this change.”
The British biotech, which landed a $10m (£8m) cash injection from Snoop Dogg five years ago, joined the London Stock Exchange in 2021. Since then, it has lost 97pc of its value. The company said it expected to go public again “in due course” but that it was more likely that this would be in the US.
Ms Sowmimo-Coker said: “We’re intending to go away for a few years and we’d hope that the London markets will have undergone a rejuvenation by then. But also Nasdaq is an opportunity and lots of others are going there.”
Ms Sowminmo-Coker said there was a “fair bit of red tape” in the market and also called for more to be done on bolstering institutional investment into companies following years of dwindling support.
The announcement will add to growing concerns over the future of the London market, which has been battling a wave of company exits in recent months. Biotechnology companies, in particular, have been vocal in their criticism of London’s public markets, which bosses have claimed is preventing early-stage research businesses from being able to spend on new treatments.
Last month, Redx Pharma said it was quitting the Alternative Investment Market (AIM), claiming its low valuation was “not conducive” to raising cash to spend on more treatments.
C4X Discovery also unveiled plans to leave AIM earlier this year, saying the recent downturn in the financial markets “adversely impacted our share price, and with it, our future ability to raise funds in the public markets”.
It prompted a warning from Sir John Bell, one of Britain’s top life sciences leaders, that more drug makers could follow. He branded the City
Exactly, this could really speed up the process
Yes just watched it with subtitles as I am in a public place without a headset. I will watch again but my first impression was that its was pressed over and over regarding the position of current shareholders and each time it sounded like they will potentially go for another public listing down the line, once they are in a bigger position and it makes sense, as Clarissa said she will be as other directors holding onto their shares. They would not be wasting time in interviews like the one watched if they didn't feel confident.
So my take is that if this is true to its word and delivers then there should be plenty of buyers coming in who are willing to let their money sit for whatever time period and come back positive, if their DD shows growth. There will be sellers also which is natural but only those who need the money urgently or for whatever legitimate reason. No one should feel under pressure to make the correct decision for themselves.
Yeah. When I bought these shares I'd not envisaged selling them at this point, and I suppose nothing has really changed in that regard. Yes, I'd expected them to have ticked up rather than down after the MHRA approval, and de-listing massively restricts buying/selling, but again - I was planning on holding onto these for a few more years anyway, so hopefully following a triumphant return to the market with a £10 share price :D
It is worth a watch.
I will hold what I have and give them the opportunity to do what they say they can do, probably a lot easier to make money without intraday nonsense and stupid valuations.
Like Clarissa said on program recently valued at 27 million and current cap just over 1m
I have a small holding in my T212 Account..
The UK Markets are getting worse as this is yet another hit I've taken recently.. Only £200 but they are all starting to really add up..
I've been around long enough to know and understand, "taking the occasional hit and moving on"..
But IMO the UK Markets are just too corrupt to call this Investing any longer.
Firstly funded
Then trials start
then USA legalising cannabis
then delist
I swear if I dont see a bid here there is an issue
Would not surprise me
Yes, it is undervalued by the market (hell - that's why we're all here...) but this has come out of leftfield. Surely a decision to delist isn't something that is agreed to in the Tuesday morning huddle following the bank holiday weekend. They must have been contemplating this for some time. Which makes the February share reissue seem a little shortsighted.
Solid buy and seems to be a lot buying.
Never seen so much volume…
Cannot believe it - felt sick seeing that news. Literally just got funded too…
We’ve seen a lot of companies have a massive bounce such as MEN etc. I wonder if we get one.
Thing is still possibility out there, we’re now valued incredibly low. Nasdaq mention would be huge and suit OCTP so much more.
Thx
Loads of buys?.
?
Only if it rockets beyond any highs known previously